Physician profile
David Robert Meyer
NPI 1487875076
$9,888.14
in general payments reported to CMS, 2019-2025
57 companies · $2,451 in 2025
The $2,451 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $987 · 2022: $1,971 · 2023: $1,935 · 2024: $2,544 · 2025: $2,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,930.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,291.13 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,027.65 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $839.08 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $722.46 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $529.44 | 2021-2025 | Jardiance, Synjardy, Ofev |
| Lilly USA, LLC | $497.42 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $397.96 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $296.88 | 2021-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Collegium Pharmaceutical, INC. | $270.64 | 2025 | Jornay Pm |
| Exact Sciences Corporation | $267.06 | 2023-2025 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $218.08 | 2022-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Bayer Healthcare Pharmaceuticals INC. | $216.05 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $190.13 | 2022-2025 | Eliquis, Camzyos |
| Otsuka America Pharmaceutical, INC. | $189.47 | 2022-2024 | Rexulti, Abilify Maintena |
| Ironshore Pharmaceuticals INC. | $187.43 | 2022-2024 | Jornay Pm |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.